• Home
  • Features
  • About
  • Market Strategy
  • Investors
  • Contact
  • Sign-up For Phase I Study
  • Bios

Become an Investor or Donor

Donate To LifeWatch Project

Help us work towards stopping the opioid crisis. Inquire below to obtain an informative brochure and learn about how T3SLA can deliver value for your investment.

Thank you for you interest!

We have received your submission and will be sending an informative investment brochure to the address you supplied. If you submitted any questions, please allow up to two business days for a response. Thank you for your interest in T3SLA!

Error

Bad respond

Your Donation Matters!

Community support and donors like you are the only reason LifeWatch exists. Your donation directly impacts the completion timeline for LifeWatch. Please consider supporting this cause aimed at saving lives and sparing family's horrible grief.
Setup 1-Time or Monthly Donation

Investors & Teamwork = Everyone Wins

We work together with communities and investors to solve problems. Investors enable project solutions to leave positive impacts on the community, and the community works together to assist in mobilizing product solutions to increase impact potential and maximize share value for investors.
Call To Invest Now
  • Top Donor Recognition (Phase I)

    The LifeWatch development team would like to recognize and thank Adam Lundquist, the Top Donor from our Phase I Fundraiser. As a result of the funds raised, our hardware designers were able to complete work on the latest version of the LifeWatch beta and produce enough casings for 15 units, which are intended for data collection with test participants.
  • Top Investor

    Over the past two years Slack Enterprises, LLC has invested significantly to help fund the continued development of LifeWatch, as well as the building where T3SLA has based business operations over the past year, which provides adequate space to separate quiet office spaces away from lab and machine spaces.
  • Top Donor (Promotional Fundraiser)

    The T3SLA community would like to give recognition to Chris Maher as being the Top Donor for our special promotional fundraiser. Thank you for your donation! This fundraiser was organized to raise funding specifically for creatimg promotional materials such as a 2-minute informative video for LifeWatch, as well as advertising campaigns. Efforts were aimed at increasing brand recognition and support for LifeWatch, and increased the project audience by almost 50,000 people.

T3SLA Philosophy Focuses on Investors and Communities Working Together to Maximize Impacts

Facilitating open dialogue and cooperation between T3SLA investors and communities looking to benefit from product solutions isn't just an optional task for us—it's derived from one of our core beliefs: A community problem requires a community solution. By including ourselves as community members and working cooperatively, we can identify the most direct and effective strategies for deploying product solutions where they are most needed and have the greatest impact. Investors ultimately make products (such as LifeWatch) possible, which directly benefit society and constituent communities. But real collaboration starts long before a product solution is ever completed. LifeWatch provides an excellent example for how T3SLA can facilitate direct collaboration with communities and deliver benefits and advantages for everyone in the process. During the course of developing LifeWatch, T3SLA began to communicate with various community members with particular significance in the affected community. In this case, substance abuse counselors, treatments centers, and other addiction services prove to be an invaluable resource to every stage of the product timeline, starting with development by providing useful feedback and bountiful access to willing volunteers, from whom ideal candidates for data gathering studies and beta testing for LifeWatch. Investors benefit directly from the accelerated pace collaboration is responsible for. The advantages to working with the community so not stop with development; at the same time the development team is benefiting from working with clinicians, management is able to work with the various institutions to identify effective deployment strategies for LifeWatch once completed. These community resources interact with unmatchable numbers when it comes to opioid users, and by working directly with medical professionals and treatment centers, we are able to develop an effective deployment strategy to get LifeWatch distributed at a rate that would otherwise be nohere close to attainable. The treatment centers and professionals working with addicts are motivated by their desire to help the most people and save lives, and that is accomplished with LifeWatch. Investors benefit again from community collaboration, bith directly from the increased revenues and profits, and indirectly from the strong reputation established by a successful launch and initial popularity of the product, which drives sales momentum higher than otherwise possible. This is just the example as takes into account the approach being taken with LifeWatch, but the principle is not limited to this project. After LifeWatch is completed, T3SLA looks forward to demonstrating the effectiveness and value to collaborating with the community has for all participants. Because when we all work together towards the same ends, we all thrive.

Our Team Works With Investors To Maximize Productivity and Deliver Value

Thomas Slack

Interim CEO
Thomas is a New Orleans native with a wide range of experience in research and development and project management. He earned his B.S. in Physics and B.A. in Communications from Loyola University New Orleans, and has roughly two decades of cummulative research experience. From 2012-15, Thomas lead the research efforts at Loyola into atmospheric conductivity measurements funded by NASA, and served as the project manager for two years. He has prior experience in developing bio-tech sensors, with intgral roles as design engineer and later as chief engineer for the tech firm Alpha Computing.
Riley Mayes
Chief Science Officer
Jill Slack, PhD
Principle Investigator Funding Allocations Director
Christopher K. Blazes, MD
Chief Medical Advisor
John T Whyte
Interim Chief Operating Officer
© Copyright 2021 by Slack Enterprises, LLC and T3SLA Innovations Inc. T3SLAinc.com, All Rights Reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories

Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.